1-3 of 3
Sandra Schmitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)

Simon P. Beyaert, Axelle E. Loriot, Nicolas D. Huyghe, Rose-Marie Goebbels, Antonella Mendola, Anne-Sophie Govaerts, Catherine Fortpied, Pamela Baldin, Lisa F. Licitra, Yassine Lalami, Paul M. Clement, Jean-Pascal H. Machiels, Sandra Schmitz
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (20): 4076–4087.
https://doi.org/10.1158/1078-0432.CCR-23-0645
Published: 13 October 2023
View article titled, Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)
Open the PDF for Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111) in another window
Includes: Supplementary data
Journal Articles

Metabolic Imaging Using Hyperpolarized Pyruvate–Lactate Exchange Assesses Response or Resistance to the EGFR Inhibitor Cetuximab in Patient-Derived HNSCC Xenografts

Lionel Mignion, Stefania Acciardo, Florian Gourgue, Nicolas Joudiou, Xavier Caignet, Rose-Marie Goebbels, Cyril Corbet, Olivier Feron, Caroline Bouzin, Patrice D. Cani, Jean-Pascal Machiels, Sandra Schmitz, Bénédicte F. Jordan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (8): 1932–1943.
https://doi.org/10.1158/1078-0432.CCR-19-1369
Published: 15 April 2020
View article titled, Metabolic Imaging Using Hyperpolarized Pyruvate–Lactate Exchange Assesses Response or Resistance to the EGFR Inhibitor Cetuximab in Patient-Derived HNSCC Xenografts
Open the PDF for Metabolic Imaging Using Hyperpolarized Pyruvate–Lactate Exchange Assesses Response or Resistance to the EGFR Inhibitor Cetuximab in Patient-Derived HNSCC Xenografts in another window
Journal Articles

HER2 and HER3 in HPV+ and HPV− HNSCC—Letter

Jean-Pascal Machiels, Rachel Galot, Sandra Schmitz
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (7): 1825.
https://doi.org/10.1158/1078-0432.CCR-15-2688
Published: 31 March 2016
View article titled, HER2 and HER3 in HPV<sup>+</sup> and HPV<sup>−</sup> HNSCC—Letter
Open the PDF for HER2 and HER3 in HPV<sup>+</sup> and HPV<sup>−</sup> HNSCC—Letter in another window